Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon

Journal of Rheumatology

Volumn 30, Issue 6, 2003, Pages 1244-1247

  Porciello, Giovanni ^a,c   Scarpato, Roberto ^a   Ferri, Clodoveo ^b   Storino, Franca ^b   Cagetti, Francesca ^b   Morozzi, Gabriella ^a   Bellisai, Francesca ^a   Migliore, Lucia ^b   Marcolongo, Roberto ^a   Galeazzi, Mauro ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Chromosomal Damage; Micronucleus Assay; Raynaud's Phenomenon; Systemic Sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; DNA TOPOISOMERASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANEUPLOIDY; ARTICLE; CELL CULTURE; CHROMOSOME ANALYSIS; CHROMOSOME DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA PROBE; EVALUATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MICRONUCLEUS; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

ADULT; AUTOANTIBODIES; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MIDDLE AGED; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 0037643322     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Masi AT, Rodnan GP, Medsger TA, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum 1980;23:581-90.
2. Le Roy EC, Black CM, Fleischmajer R, et al. Scleroderma (systemic sclerosis). Classification, subset and pathogenesis. J Rheumatol 1988;15:202-5.
3. Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990;16:11-30.
4. Hirschl M, Kundi M. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology. J Rheumatol 1996;23:302-9.
5. Emerit I, Housset J, De Grouchy J, Camus JP. Chromosomal breakage in diffuse scleroderma. A study of 27 patients. Eur J Clin Biol Res 1971;16:684-94.
6. Pan SF, Rodnan GP, Deutsch M, Wald N. Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects. J Lab Clin Med 1975;86:300-8.
7. Migliore L, Bevilacqua C, Scarpato R. Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus and systemic sclerosis patients. Mutagenesis 1999;14:227-31.
8. Sherer GK, Jackson BB, Le Roy EC. Chromosome breakage and sister chromatid exchange frequencies in scleroderma. Arthritis Rheum 1981;24:1409-13.
9. Wolff DJ, Needleman BW, Wasserman SS, Schwartz S. Spontaneous and clastogen induced chromosomal breakage in scleroderma. J Rheumatol 1991;18:837-40.
10. Emerit I. Chromosomal instability in collagen disease. Z Rheumatol 1980;39:84-90.
11. Galeazzi M, Anichini C, Morozzi G, Bellisai F, Puddu P, Marcolongo R. Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients. Clin Rheumatol 1996;15:418-9.
12. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med 1994;16:99-109.
13. Emerit I, Filipe P, Meunier P, et al. Clastogenic activity in the plasma of scleroderma patients: a biomarker of oxidative stress. Dermatology 1997;194:140-6.
14. Sambo P, Jannino L, Candela M, et al. Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion. J Invest Dermatol 1999;112:78-84.
15. Sambo P, Baroni SS, Luchetti M, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive upregulation of reactive oxigen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001;44:2653-64.
16. Herrick AL, Matucci Cerinic M. The emerging problem of oxidative stress and the role of ant-oxidants in systemic sclerosis. Clin Exp Rheumatol 2001;19:4-8.
17. Jabs EW, Tuck-Muller CM, Anhalt GJ, Earnshaw W, Wise RA, Wigley F. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies. Cytogenet Cell Genet 1993;63:169-75.
18. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993;285:35-44.
19. Scarpato R, Landini E, Migliore L. Acrocentric chromosome frequency in spontaneous human lymphocyte micronuclei, evaluated by dual-colour hybridization, is neither sex- nor age-related. Mutat Res 1996;372:195-204.
20. Emerit I, Garban F, Vassy J, Levy A, Filipe P, Freitas J. Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase. Proc Natl Acad Sci USA 1996;93:12799-804.
21. Powell FC, Schroeter AL, Winkelmann RK, Dewald GW. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity. Acta Dermatol Venereol 1986;66:414-8.
22. Foster MH, Kieber-Emmons T, Ohliger M, Madaio MP. Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies. Immunol Res 1994;13:186-206.
23. Yanase K, Smith RM, Cizman B, et al. A subgroup of murine monoclonal antideoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time- and temperature-dependent manner. Lab Invest 1994;71:52-60.